Jiangsu Hualv Biological Technology Co.Ltd. Market Cap ($281.96 Million)
Market Cap & Net Worth: Jiangsu Hualv Biological Technology Co.Ltd. (300970)
Jiangsu Hualv Biological Technology Co.Ltd. market cap. Jiangsu Hualv Biological Technology Co.Ltd. (SHE:300970) has a market capitalization of $281.96 Million (CN¥1.93 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #14852 globally and #4365 in its home market, demonstrating a -2.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Hualv Biological Technology Co.Ltd.'s stock price CN¥12.05 by its total outstanding shares 159903870 (159.90 Million). Also see cash efficiency ratio of Jiangsu Hualv Biological Technology Co.L for how efficiently the company converts equity into cash flow.
Jiangsu Hualv Biological Technology Co.Ltd. Market Cap History (2021–2026)
Jiangsu Hualv Biological Technology Co.Ltd. market cap history from 2021 to 2026. Data shows change from $666.45 Million to $281.96 Million (-19.60% CAGR). Check Jiangsu Hualv Biological Technology Co.L (300970) stock price for real-time trading data and today's change.
Jiangsu Hualv Biological Technology Co.Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Hualv Biological Technology Co.Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300970 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.37x
Jiangsu Hualv Biological Technology Co.Ltd.'s market cap is 0.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.35x
Jiangsu Hualv Biological Technology Co.Ltd.'s market cap is 4.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $666.45 Million | $578.09 Million | $15.50 Million | 1.15x | 42.98x |
| 2022 | $406.68 Million | $751.59 Million | $78.25 Million | 0.54x | 5.20x |
| 2023 | $397.88 Million | $996.22 Million | $30.35 Million | 0.40x | 13.11x |
| 2024 | $278.45 Million | $1.03 Billion | -$47.57 Million | 0.27x | N/A |
| 2025 | $479.91 Million | $1.29 Billion | $110.27 Million | 0.37x | 4.35x |
Competitor Companies of 300970 by Market Capitalization
Companies near Jiangsu Hualv Biological Technology Co.Ltd. in the global market cap rankings as of November 6, 2026. Also see 300970 total assets for a full breakdown of the balance sheet.
Key companies related to Jiangsu Hualv Biological Technology Co.Ltd. by market ranking:
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #782 globally with a market cap of $34.48 Billion USD ( CN¥235.61 Billion CNY).
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #806 globally with a market cap of $33.40 Billion USD.
- Bunge Limited (NYSE:BG): Ranked #1321 globally with a market cap of $18.77 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1459 globally with a market cap of $16.92 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #782 | Muyuan Foodstuff Co Ltd | SHE:002714 | $34.48 Billion | CN¥43.13 |
| #806 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $70.84 |
| #1321 | Bunge Limited | NYSE:BG | $18.77 Billion | $97.01 |
| #1459 | Tyson Foods Inc | NYSE:TSN | $16.92 Billion | $60.03 |
Market Capitalization of Jiangsu Hualv Biological Technology Co.Ltd. (2021–2026)
Market capitalization of Jiangsu Hualv Biological Technology Co.Ltd. from 2021 to today. Between 2021 and today, Jiangsu Hualv Biological Technology Co.Ltd.'s market cap moved from $666.45 Million to $ 281.96 Million, with a yearly change of -19.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥281.96 Million | -41.25% |
| 2025 | CN¥479.91 Million | +72.35% |
| 2024 | CN¥278.45 Million | -30.02% |
| 2023 | CN¥397.88 Million | -2.16% |
| 2022 | CN¥406.68 Million | -38.98% |
| 2021 | CN¥666.45 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Jiangsu Hualv Biological Technology Co.Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $281.96 Million USD |
| MoneyControl | $281.96 Million USD |
| MarketWatch | $281.96 Million USD |
| marketcap.company | $281.96 Million USD |
| Reuters | $281.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Hualv Biological Technology Co.Ltd.
Jiangsu Chinagreen Biological Technology Group Co.,Ltd. engages in the research, development, factory cultivation, and sale of edible fungi in China. It offers Flammulina velutipes; Pleurotus eryngii, including white jade mushroom and oyster mushroom; and Maitake mushrooms. The company was founded in 2010 and is headquartered in Suqian, China.